Schaeffer's Top Stock Picks for '25

CarMax, Wynn Resorts, Dynavax Stocks Moving Today

CarMax, Inc (KMX), Wynn Resorts, Limited (WYNN), and Dynavax Technologies Corporation (DVAX) are three stocks making notable moves on the charts today

Mar 1, 2017 at 2:34 PM
facebook X logo linkedin


The Trump rally has resumed after the president's first address to Congress, with the Dow soaring past the 21,000 level. Among specific equities in focus are auto sales specialist CarMax, Inc (NYSE:KMX), casino stock Wynn Resorts, Limited (NASDAQ:WYNN), and biotech concern Dynavax Technologies Corporation (NASDAQ:DVAX). Here's a quick look at what's moving shares of KMX, WYNN, and DVAX.

Chanos Short Position Sends CarMax on a Wild Ride

Shares of KMX took a sharp dip near midday, falling nearly 3% following reports Jim Chanos has taken a short position on the stock. It didn't take long for the security to climb back into positive territory, though, last seen up 1.1% at $65.26 amid unusually high volume. In fact, intraday stock volume is running in the 99th percentile of its annual range, at last check. The quick recovery could come as a disappointment to other short sellers. At present, 10.7% of CarMax, Inc's total float is wrapped up in these pessimistic positions, accounting for nearly 12 sessions' worth of trading, at the stock's average daily volumes. These bears could already be on edge, though, considering KMX is sitting on a 36.8% year-over-year lead. 

Wynn Resorts Gets a Lift from Macau Data

WYNN is soaring 7.1% to $102.96 today after gambling revenue out of Macau rose to a two-year high, climbing for a seventh straight month. The stock is off to a solid start in 2017, up 19%, after notching a series of higher lows over the past four months and recently bouncing off support at the 80-day moving average. That doesn't seem to be impressing analysts, however. Out of 15 firms providing coverage, 11 rate Wynn Resorts, Limited a "hold" or "strong sell."

FDA Nod Sends Dynavax Soaring

The U.S. Food and Drug Administration (FDA) last night announced it has accepted DVAX's hepatitis B vaccine for review -- news that helped the stock surge 56.1% to $7.03, making it the top gainer on the Nasdaq. A previous FDA rejection of the drug sent the stock spiraling back in November. As it stands, DVAX has a lot of ground to make up, with the shares still down 60% year-over-year. It's therefore not surprising Dynavax Technologies Corporation has been targeted by short sellers in recent months. Even after falling nearly 11% in the past two reporting periods, these bearish bets represent 22% of the stock's total float, which would take more than three weeks to cover, at DVAX's typical pace of trading. 

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter